<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We examined the postprandial <z:chebi fb="105" ids="17234">glucose</z:chebi> regulators nateglinide and GLP-1, separately and in combination, in people with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>Nateglinide inhibited DPP-4 activity, reduced GLP-1 degradation and enhanced its insulinotropic and blood <z:chebi fb="105" ids="17234">glucose</z:chebi> lowering effect </plain></SENT>
<SENT sid="2" pm="."><plain>Combining nateglinide and GLP-1 derivatives may effectively control postprandial glycaemia </plain></SENT>
</text></document>